• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Zyprexa Relprevv (Olanzapine) for Extended-release Injectable Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August 2012

Summary View

 

MEDICATION GUIDE

  • Before you receive Zyprexa Relprevv treatment you must……
  • Post-injection Delirium Sedation Syndrome (PDSS)….
  • seizures (convulsions)
  • You will need to stay at the clinic where you receive the injection for at least 3 hours so your doctor can make sure you do not have symptoms of PDSS…